Paramed

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Paramed

Understanding Paramed

Paramed is a medicinal product categorized as an analgesic and antipyretic. It is primarily utilized to manage mild to moderate pain and to assist in the reduction of elevated body temperature.

Mechanism of Action

The active components in Paramed work by inhibiting the synthesis of prostaglandins in the central nervous system. Prostaglandins are naturally occurring chemicals in the body that transmit pain signals and play a role in the regulation of body temperature. By reducing the production of these substances, the medication helps to elevate the pain threshold and facilitate heat loss through vasodilation and increased peripheral blood flow.

Therapeutic Indications

Paramed is commonly used for the symptomatic relief of various conditions, including:

  • Headaches and migraines
  • Muscle aches and back pain
  • Dental pain
  • Menstrual cramps
  • Discomfort associated with the common cold and flu
  • Febrile states (fever)

Formulations

This medication is available in several forms to accommodate different patient needs, including oral tablets, capsules, and liquid suspensions. The choice of formulation typically depends on the patient's age and their ability to ingest solid oral dosage forms. While it is effective for temporary symptom relief, it does not treat the underlying cause of pain or fever.

Regulatory References

  1. WHO Essential Medicines List for Paracetamol

What side effects are possible with Paramed?

Possible side effects and safety information

The safety profile of Paramed (Acetaminophen) is officially documented by regulatory authorities, with specific risks classified by the system affected and their reported frequency. The most critical documented safety concern is the potential for hepatotoxicity (liver damage), including the risk of acute liver failure, which is primarily associated with single acute overdose or excessive chronic use.

Documented Adverse Reactions and Frequencies

Adverse reactions that are explicitly listed in regulatory labeling are categorized based on their occurrence rate:

  • Rare effects (ge 1/10,000 to < 1/1,000) include general hypersensitivity reactions and disorders of the Blood and lymphatic system, such as thrombocytopenia.
  • Very Rare effects (< 1/10,000) include Severe Cutaneous Adverse Reactions (SCARs), like Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), which affect the Skin and subcutaneous tissue disorders system.

Serious Safety Considerations

Serious adverse reactions, which require specific attention in official labeling, include Acute Liver Failure and severe, immediate allergic responses such as Anaphylactic Shock. These effects define the most serious potential outcomes of exposure.

Safety documents also identify specific populations at heightened risk. Individuals with pre-existing hepatic impairment, severe active liver disease, or a history of chronic alcohol use are noted to be particularly susceptible to adverse effects affecting the Hepatobiliary disorders system. The primary high-level safety constraint is the explicit warning against combining Paramed with any other product that also contains acetaminophen.

Overdose and Emergency Response

Overdose and when to Seek Help

The official regulatory profile for Paramed (Acetaminophen/Paracetamol) overdose centers on the risk of severe, delayed organ damage.

When to Seek Immediate Help

Immediate medical attention must be sought if an overdose is suspected, even if the patient feels well. This requirement is mandated because the most serious outcome, severe liver damage (hepatic necrosis), can progress to acute liver failure and death, but initial symptoms are often delayed or absent. The risk of fatal outcomes makes immediate intervention critical. Treatment with the specific antidote, N-acetylcysteine (NAC), is time-critical, with effectiveness declining sharply after eight hours post-ingestion. For emergency guidance, contact a poison control center or call emergency services right away.

Documented Overdose Manifestations

Initial signs of overdose, which may take several days to appear, include pallor, nausea, vomiting, loss of appetite, sweating, and abdominal pain. These symptoms may initially mimic common illnesses. As toxicity progresses, regulatory documents list severe manifestations such as the yellowing of the skin and eyes (jaundice), dark urine, confusion, and seizures. Severe cases may require hospital monitoring of hepatic and renal function (assessed by lab tests like ALT and INR) to determine the extent of organ injury and the need for procedures such as liver transplantation. Overdose management is modified for patients with pre-existing hepatic impairment or for ingestion of modified-release formulations.

Therapeutic Uses of Paramed

Paramed is commonly used for managing symptoms related to physical discomfort and systemic imbalance. This medication is relevant in clinical settings that involve acute or unstable symptom patterns.

It is commonly used to help with symptomatic relief for mild to moderate pain episodes, such as tension headaches, muscular aches, and menstrual cramps, and is applied in addressing elevated body temperature (fever). It provides supportive relief when symptoms interfere with routine activities, which supports the patient during difficult episodes by easing distress.

The medication is relevant in contexts marked by increased discomfort, often applied during phases when symptoms become more noticeable due to seasonal illnesses like the common cold or flu, or following dental procedures or vaccinations. This contributes to easing the overall symptom load and supports general well-being during symptomatic phases.

Fact Sheet: Therapeutic Focus
Primary Focus Mild to Moderate Pain, Pyrexia
Symptom Clusters Aches, malaise, temperature elevation
Primary Therapeutic Benefit Supportive symptomatic relief

Regulatory References

  1. National Institute of Health (NIH) MedlinePlus

Eligibility and Restrictions for Use

Who can and cannot use Paramed?

This section describes official population eligibility and non-eligibility rules for Paramed (Acetaminophen/Paracetamol), as defined by government regulatory bodies.

Contraindications and Restrictions

Classification Population/Condition
Absolute Contraindication Patients with known hypersensitivity or allergy to Acetaminophen or any of the product's excipients.
Absolute Contraindication Patients with severe hepatic impairment or severe active liver disease.
Restricted Use Patients with severe renal impairment (typically CrCl le 30 mL/min).
Restricted Use Patients with chronic alcoholism or chronic malnutrition.

Age and Physiological Status Eligibility

Adults and adolescents are generally eligible for use. For children, eligibility is dependent on minimum age and weight thresholds that vary by product formulation. Safety and effectiveness have not been established for certain specific formulations, such as the intravenous route, in pediatric patients younger than 2 years of age.

Pregnancy and lactation status do not constitute absolute contraindications. Use is generally permitted when clinically necessary, with regulatory advice emphasizing the use of the lowest effective dose for the shortest duration.

What should I know about interactions with other medicines?

Paramed's active ingredient is paracetamol (acetaminophen). The risk of adverse events or changes in drug effect increases when it is used alongside other medicines.

Do not take Paramed with any other product, prescription or over-the-counter, that also contains paracetamol, as this significantly increases the risk of severe liver damage due to overdose.

Potential Drug Interactions

  • Blood Thinners: Regular or prolonged use of Paramed may enhance the effect of warfarin and other coumarin-derivative blood thinners, increasing the risk of bleeding. Close monitoring of clotting factors by a healthcare provider is necessary.
  • Medicines for Nausea/Vomiting: Certain drugs used to treat nausea or vomiting, such as metoclopramide and domperidone, may increase the rate at which Paramed is absorbed, leading to a faster onset of action.
  • Cholesterol-Lowering Medicines: Cholestyramine, used to lower blood cholesterol, can decrease the absorption of paracetamol, potentially reducing its effectiveness.
  • Anti-Infectives: Chloramphenicol may have its concentration in the body increased when taken with paracetamol.
  • Anti-epileptics and Tuberculosis Medicines: Medicines like phenytoin, phenobarbital, or rifampicin can affect how the liver processes Paramed, which may increase the risk of liver toxicity.

Always inform your doctor or pharmacist of all medicines, supplements, and herbal products you are currently using to ensure a safe and effective treatment regimen.

Mechanism of Action

Central Modulation of Thermoregulation

The drug acts through the Central Nervous System (CNS), primarily by inhibiting Cyclooxygenase (COX) enzymes within the hypothalamus. This interaction restricts the synthesis of Prostaglandin E2 (PGE2), a key mediator responsible for elevating the body's temperature set point. The resulting physiological consequence is the downward resetting of this set point, which prompts the body to initiate cooling mechanisms, such as sweating and vasodilation, to dissipate excess heat.

Dual-Path Modulation of Central Nociceptive Signaling

The drug's action against nociceptive signaling is also focused on the CNS, operating through at least two complementary pathways. It modulates nociceptive input via COX enzyme inhibition in spinal and supraspinal pathways. Additionally, its active metabolite, AM404, indirectly engages the endocannabinoid system. AM404 blocks the reuptake of Anandamide, increasing its local concentration to modulate pain transmission through TRPV1 receptors. These distinct central mechanisms collectively result in the dampening and desensitization of nociceptive signals.

Mechanistic Limitation: Weak Peripheral Anti-Inflammatory Action

Its mechanism exhibits weak inhibition of COX enzymes in the presence of high peroxide concentrations, which are characteristic of acute inflammatory sites. This functional constraint means the drug's physiological contribution is primarily confined to CNS-mediated effects, with minimal impact on peripheral inflammatory processes.

Dosage and Administration Information

The use of Paramed (Acetaminophen/Paracetamol) involves specific routes, dosage parameters, and frequency schedules. The medicine is available for oral (tablets, solutions), rectal (suppositories), and intravenous (IV) infusion administration.

Official Dosing and Frequency

Standard adult dosing for oral administration typically ranges from 650 mg to 1,000 mg per dose. All doses must be separated by a mandatory minimum interval of four hours, regardless of the administration route or specific formulation used. The total amount of the active ingredient consumed from all sources (including prescription and non-prescription products) must not exceed a Maximum Total Daily Dose of 4,000 mg over a 24-hour period.

Administration Conditions

Oral forms may be taken with or without food. For proper use of liquid suspensions, the container must be shaken well, and the dose must be measured accurately using the provided dosing device. Intravenous administration is a procedural condition requiring the solution to be delivered via slow infusion over approximately 15 minutes.

Population and Procedural Rules

Dosing for pediatric patients and smaller adults (under 50 kg) is weight-based, ensuring precise administration. Furthermore, special procedural constraints exist for specific forms; for instance, extended-release tablets must be swallowed whole and must not be crushed or split to maintain their intended release profile. Patients with hepatic or severe renal impairment require a reduced total daily dosage.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Paramed

Research Evidence for Relief of Mild to Moderate Pain (Analgesia)

Research exploring the evidence for Paramed relevant to physical discomfort outcomes is primarily composed of randomized controlled trials (RCTs) and comprehensive meta-analyses. This evidence base has been used in research exploring how symptoms change over time, and what populations were included, in studies that have monitored short-term pain intensity measurements. Study outcomes examined typically involve measurements of pain intensity, such as the change in reported pain scores, the time until subjects noted an onset, and the duration of any change in discomfort. Studies examined outcomes in general adult populations, as well as in specific groups defined by conditions involving periods of heightened symptoms, such as tension headaches and those following dental procedures.

Research Evidence for Reduction of Fever (Antipyresis)

Research exploring the evidence for Paramed relevant to outcomes related to elevated body temperature was conducted, consisting of a large volume of RCTs and numerous systematic reviews. These studies have been applied in research contexts involving fluctuating or unstable symptoms, particularly in populations defined by temporary physiological imbalance. Research examined outcomes related to physiological strain, specifically changes in measured body temperature and the time recorded for a decrease in fever. Research explored short-term symptom changes in populations defined by conditions involving periods of heightened symptoms, including both adults and children and infants, often related to common illnesses or after vaccinations.

Studies in Special Populations

Research explored the administration of Paramed in specific populations, including pregnant individuals, primarily through large-scale observational cohort studies. These studies monitored outcomes linked to inflammatory states and tracked long-term results in offspring to explore associations with neurodevelopmental markers. Conventional observational research described associations with certain neurodevelopmental outcomes; however, methodologically stronger studies, such as those that compared siblings where only one was exposed, described patterns where this association was substantially reduced or not observed. The studies suggest that initial associations may be influenced by factors shared within the family or by the underlying indication for use.

Evidence Gaps and Areas of Scientific Uncertainty

While research describes consistent patterns for short-term, acute outcomes related to pain and fever, data are still emerging in several areas. Chronic pain remains an area of uncertainty; the data show patterns related to physical discomfort in acute settings, but evidence is limited for many long-term, chronic conditions. Comparative evidence is lacking for certain specific patient groups. Furthermore, subgroup findings are uncertain for certain comorbidity-defined groups, meaning results apply only to the general populations studied.

Key Studies & References

  1. Acetaminophen (Paracetamol) Monograph: LiverTox
  2. Efficacy and Safety of Oral Paracetamol in Acute Pain: A Systematic Review and Meta-analysis
  3. WHO Model List of Essential Medicines
  4. Guidance on the use of paracetamol in children (e.g., fever management)

Frequently Asked Questions (FAQ)

Common questions about Paramed (FAQ)

Q: Why do some people say Paramed causes drowsiness?

A: Regulatory documents for single-ingredient Paramed (acetaminophen) do not typically list drowsiness as a direct or frequent side effect. However, this medicine is often included in combination products alongside other active ingredients, such as certain antihistamines or sedatives, which are known to cause drowsiness. The experience of sleepiness is most likely related to the use of one of these combination formulas.

Q: How long does one dose of Paramed typically last in the body?

A: Official documentation describes the time it takes for the active ingredient to be eliminated from the body. The half-life—the time required for the amount of medicine in the body to decrease by half—is described as ranging between 1.9 to 2.5 hours. Regulatory guidance describes that doses should be separated by a minimum interval of four hours to maintain safety.

Q: What should I do if I notice an unexpected side effect from Paramed?

A: Official product information describes that signs of a serious or severe reaction, such as difficulty breathing, swelling of the face, or a severe skin rash, indicate the medicine should be discontinued and emergency medical assistance sought. In the event of other unexpected symptoms, official guidance suggests discontinuing the medicine and contacting a healthcare professional for consultation.

Q: How do I know if Paramed is working for me?

A: According to official information, the medicine is effective if there is a measurable reduction in your symptoms, such as the lowering of an elevated body temperature (fever) or a decrease in reported mild to moderate physical discomfort. Official labeling states that if fever lasts more than 3 days or pain lasts more than 10 days, consultation with a healthcare professional is recommended.

Q: Why is Paramed sometimes prescribed for conditions other than pain?

A: The medicine is officially approved for two main therapeutic uses: the relief of mild to moderate pain (analgesia) and the reduction of fever (antipyresis). These are the only conditions described in regulatory documents for its approved use.

Q: Is Paramed the same kind of medicine as [similar common drug name]?

A: Paramed is officially classified as an analgesic and antipyretic medicine. Regulatory documents describe its action as primarily centered on the Central Nervous System (CNS), where it works to inhibit certain enzymes that modulate temperature and pain signals.

Q: How quickly should I expect to feel an effect after taking Paramed?

A: Official pharmacokinetic data indicate that the onset of action for an oral dose of the active ingredient is typically noted within approximately 30 to 60 minutes after administration. This information describes the general timeframe for when effects are observed in studies.

Q: Can Paramed be taken with common vitamins or supplements?

A: Regulatory documentation notes that certain supplements, especially herbal products, may potentially alter the absorption or increase the risk of adverse effects associated with Paramed. Official labeling indicates that users are advised to inform a healthcare professional of all supplements and vitamins they are currently taking.

Q: Is Paramed safe for long-term use?

A: Official Over-The-Counter (OTC) labeling recommends that use for the treatment of pain should not exceed 10 days and use for fever should not exceed 3 days, unless specific instructions for extended use have been provided by a healthcare professional. For chronic use, even at therapeutic doses, official guidance indicates that regular monitoring may be necessary.

Q: Are there any common foods or drinks that interact with Paramed?

A: Official documents state that oral forms of the medicine may be taken with or without food. Regulatory warnings describe that chronic, excessive consumption of alcohol carries an increased risk of severe liver damage and is therefore officially cautioned against.

Q: Can Paramed affect my ability to drive or operate machinery?

A: Regulatory labeling for the single-ingredient form of Paramed does not typically include specific warnings about driving or operating machinery. However, if Paramed is co-formulated with certain other ingredients (such as those that cause drowsiness), warnings regarding mental alertness and coordination are included.

Q: What should I know about Paramed if I have kidney issues?

A: Official regulatory documents explicitly state that patients with severe renal (kidney) impairment require a specific reduction in the total daily dosage of Paramed. This measure is necessary to prevent accumulation of the medicine in the body, which could lead to potential adverse effects.

Q: Can I take Paramed if I am currently taking an antidepressant?

A: Official labeling indicates that users are advised to inform a healthcare professional of all medicines, including antidepressants, that are being taken. While many antidepressants do not have major listed interactions, some combinations may warrant professional monitoring or dose adjustment, particularly for potential bleeding risk.

Q: Does the time of day I take Paramed matter?

A: Official regulatory documents focus on safety and efficacy, emphasizing the critical importance of maintaining the mandatory minimum interval of four hours between doses and ensuring the Maximum Total Daily Dose is not exceeded. They do not stipulate a required time of day for administration.

Q: Are there any known interactions between Paramed and herbal remedies?

A: Regulatory documentation advises caution regarding herbal products. Some herbal remedies, particularly those that may affect the liver function, are documented as having the potential to interact with Paramed and increase the risk of adverse events. Official guidance suggests that users disclose all herbal product use to a healthcare professional.

Q: Does Paramed show up on drug tests?

A: The active ingredient in Paramed can be measured in a specific blood test, called an acetaminophen level test, which is used in clinical settings to monitor for toxicity or potential overdose. It is not generally included in the common screening panels for drugs of abuse.

Q: Is it true that Paramed works by [a specific incorrect mechanism]?

A: Official labeling defines the mechanism of action as primarily involving the inhibition of specific enzymes (Cyclooxygenase, or COX) in the Central Nervous System (CNS), specifically within the hypothalamus. This action modulates the body's set point for temperature and dampens pain signals.

Q: Can taking Paramed make me feel dizzy or lightheaded?

A: Dizziness and lightheadedness are not typically listed as common or frequent side effects of the single-ingredient product in regulatory labeling. These effects are sometimes observed when the medicine is taken in a combination product that includes other active ingredients.

Q: Are there different strengths or formulations of Paramed?

A: Yes, official regulatory documents describe that the medicine is manufactured in various approved forms. These forms include oral tablets, liquid solutions, rectal suppositories, and intravenous infusions, available in different strengths for use in adults and pediatric patients.

Q: What is the difference between the [Brand Name] and the generic version of Paramed?

A: According to regulatory standards, the active ingredient in both the brand-name and the generic version must be the same. Generic versions are required to deliver the same amount of the active ingredient to the body as the brand-name product. Differences may exist only in inactive components, such as coloring or binding agents.

Q: Can I use Paramed if I have high blood pressure?

A: Single-ingredient Paramed is generally not listed as being contraindicated for individuals with high blood pressure. However, regulatory warnings explicitly state that combination products that contain additional ingredients, such as nasal decongestants, are cautioned against for individuals with high blood pressure.

Q: Are there any lifestyle changes that are recommended while using Paramed?

A: Official patient guidance emphasizes reading all labels carefully to avoid inadvertently taking more than one product containing the active ingredient at the same time. Guidance also advises limiting or avoiding alcohol consumption due to the increased risk of liver toxicity.

Q: What are the reasons someone might stop taking Paramed?

A: Official warnings in labeling list specific reasons to discontinue the medicine. These include experiencing signs of a severe allergic reaction, noticing symptoms indicative of liver injury (such as yellowing of the skin), or if the underlying pain or fever worsens or persists beyond the short-term limits noted on the label.

Q: How long can I continue to use Paramed safely?

A: Official Over-The-Counter (OTC) product instructions generally limit use for pain relief to 10 days and for fever reduction to 3 days. These are the short-term limits established by regulatory bodies unless the extended use has been specifically supervised by a healthcare provider.

Q: Is Paramed affected by drinking alcohol?

A: Yes, regulatory labeling contains an explicit warning regarding alcohol use. Chronic, excessive consumption of alcohol significantly increases the potential for severe liver damage and acute liver failure when combined with the active ingredient.

Q: Is Paramed approved for long-term chronic conditions?

A: The drug is officially approved for the relief of mild to moderate acute pain and for the reduction of fever. While it may be used under professional supervision for chronic symptoms, the research evidence section notes that data are limited and uncertain regarding its effectiveness in many long-term, chronic conditions.

Q: Can Paramed interact with birth control pills?

A: Some studies suggest that certain oral contraceptives may potentially reduce or delay the effects of Paramed by affecting how quickly it is broken down in the body. However, official regulatory information describes that concurrent use with usual therapeutic doses is generally considered to carry no significant additional risk.

Q: Why do official documents mention 'risk-benefit profile' for Paramed?

A: Regulatory bodies use the term 'risk-benefit profile' to communicate their official determination that, when the medicine is used strictly as directed and within labeled dosage limits, the documented therapeutic benefits (pain and fever relief) are considered to outweigh the potential documented risks (such as liver damage or allergic reactions).

Q: Does Paramed affect sleep patterns?

A: The single-ingredient form of the medicine is not typically associated with disrupting sleep patterns. However, certain combination products containing Paramed are specifically intended to be taken at bedtime because they include an additional active ingredient, such as an antihistamine, that promotes drowsiness.

Q: How is Paramed eliminated from the body?

A: The active ingredient is primarily processed, or metabolized, by the liver into inactive components. These processed components are then mainly removed from the body through excretion by the kidneys.

How should Paramed be stored and disposed of?

How to Store and Dispose of Paramed?

The official storage and disposal requirements for Paramed (Acetaminophen) are strictly defined by regulatory documents to maintain product quality and safety.

Mandatory Storage Requirements

Condition Requirement
Temperature Store at room temperature, generally between 20 C and 25 C (68 F to 77 F). Do not refrigerate or freeze.
Environment Keep the medicine in a dry place, away from excess heat and moisture (e.g., not in the bathroom). Store in the original container and keep it tightly closed to protect from light.

Safety and Disposal Rules

Child Protection: It is mandatory to keep Paramed out of the sight and reach of children by using a safety-capped container and securing it in a locked location.

Disposal: Unused or expired Paramed must not be flushed down the toilet or poured down the drain. Consumers should utilize a drug take-back program or follow the official governmental method for disposing of medicines in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paramed found in:

A-Z Index: